How M.D. was paid
$1.2M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Bonus | Stock | Options | Incentive | Other | Total |
|---|---|---|---|---|---|---|---|
| Deborah Birx, M.D.Chief Executive Officer | $562,380 | — | $397,981 | $281,190 | $259,350 | $8,338 | $1,249,889 |
| Pierre Kyme, Ph.D.Chief Business Officer | $412,000 | $1,000 | — | $165,825 | $206,000 | $6,750 | $791,575 |
| David HouseSenior Vice President, Finance and Principal Financial Officer | $360,500 | $1,000 | — | $41,456 | $144,200 | $7,614 | $554,770 |
What changed and why
- $1.2MChief Executive Officer Deborah Birx received a total compensation of $1,249,889 in fiscal 2025.
- $1.8MDeborah Birx's total compensation decreased from $1,843,527 in fiscal 2024 to $1,249,889 in fiscal 2025.
- $792KChief Business Officer Pierre Kyme received total compensation of $791,575 in fiscal 2025.
- $555KSenior Vice President David House received total compensation of $554,770 in fiscal 2025.
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.